Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:936062.
doi: 10.1155/2015/936062. Epub 2015 Jul 12.

Utility of C-Reactive Protein Levels for Early Prediction of Dengue Severity in Adults

Affiliations

Utility of C-Reactive Protein Levels for Early Prediction of Dengue Severity in Adults

Chien-Chih Chen et al. Biomed Res Int. 2015.

Abstract

Dengue has broad clinical presentation with unpredictable clinical evolution and outcome. We aimed to evaluate the utility of C-reactive protein (CRP) levels for distinguishing between mild and severe cases in the early phase of the dengue illness. We retrospectively evaluated adults with dengue from 2006 to 2014, according to 1997 and 2009 World Health Organization (WHO) criteria for severity. Of 191 included patients, 32.9% had nonshock dengue hemorrhagic fever (DHF), 3.1% dengue shock syndrome (DSS), and 7.9% severe dengue. The risk of DHF/DSS and severe dengue is significantly related to the increasing levels of CRP. Of 191 patients, 97 had CRP levels measured during the febrile (days 1-3); 85 during the critical (days 4-6); and 9 during the convalescent (days 7-10) illness phases. During the febrile phase, there was significant higher CRP level for DSS versus DF/nonshock DHF and severe dengue versus nonsevere dengue, with CRP cutoff level 30.1 mg/L (area under the receiver operating characteristic curve (AUC), 0.938; 100% sensitivity, 76.3% specificity) and 24.2 mg/L (AUC, 0.717; 70% sensitivity, 71.3% specificity), respectively. Our study highlights the utility of the CRP levels in early prediction of DSS and severe dengue in adult patients.

PubMed Disclaimer

References

    1. Simmons C. P., Farrar J. J., van Vinh Chau N., Wills B. Dengue. The New England Journal of Medicine. 2012;366(15):1423–1432. doi: 10.1056/nejmra1110265. - DOI - PubMed
    1. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. Geneva, Switzerland: World Health Organization; 1997.
    1. Deen J. L., Harris E., Wills B., et al. The WHO dengue classification and case definitions: time for a reassessment. The Lancet. 2006;368(9530):170–173. doi: 10.1016/s0140-6736(06)69006-5. - DOI - PubMed
    1. Bandyopadhyay S., Lum L. C. S., Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Tropical Medicine and International Health. 2006;11(8):1238–1255. doi: 10.1111/j.1365-3156.2006.01678.x. - DOI - PubMed
    1. World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: World Health Organization; 2009. - PubMed